Massive parallel sequencing
Advanced DNA sequencing technology
Template:Infobox medical technology
Massive Parallel Sequencing (MPS), also known as Next-Generation Sequencing (NGS), is a high-throughput method used to determine the sequence of nucleotides in DNA or RNA samples. This technology allows for the rapid sequencing of large amounts of genetic material, making it a powerful tool in genomics, transcriptomics, and epigenomics.
Overview[edit | edit source]
Massive Parallel Sequencing technologies have revolutionized the field of genomics by providing a cost-effective and efficient means of sequencing DNA and RNA. Unlike traditional Sanger sequencing, which sequences one DNA fragment at a time, MPS can sequence millions of fragments simultaneously, significantly increasing throughput and reducing costs.
Applications[edit | edit source]
MPS is used in a variety of applications, including:
- Whole genome sequencing
- Exome sequencing
- RNA-Seq for transcriptome analysis
- ChIP-Seq for studying protein-DNA interactions
- Metagenomics
- Cancer genomics
Technology[edit | edit source]
There are several platforms for Massive Parallel Sequencing, each with its own unique chemistry and methodology. Some of the most widely used platforms include:
- Illumina sequencing
- Ion Torrent sequencing
- Pacific Biosciences sequencing
- Oxford Nanopore sequencing
Advantages[edit | edit source]
- High throughput: Ability to sequence millions of fragments simultaneously.
- Cost-effective: Reduced cost per base compared to traditional methods.
- Versatile: Applicable to a wide range of biological questions.
Challenges[edit | edit source]
Despite its advantages, MPS also presents several challenges, such as:
- Data analysis: The large volume of data generated requires sophisticated bioinformatics tools for analysis.
- Error rates: Different platforms have varying error rates that need to be accounted for.
- Sample preparation: Requires careful preparation to avoid biases.
See also[edit | edit source]
References[edit | edit source]
External links[edit | edit source]
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
WikiMD's Wellness Encyclopedia |
Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD